vs

Side-by-side financial comparison of Bausch & Lomb Corp (BLCO) and LCI INDUSTRIES (LCII). Click either name above to swap in a different company.

Bausch & Lomb Corp is the larger business by last-quarter revenue ($1.4B vs $932.7M, roughly 1.5× LCI INDUSTRIES). LCI INDUSTRIES runs the higher net margin — 2.0% vs -4.1%, a 6.1% gap on every dollar of revenue. On growth, LCI INDUSTRIES posted the faster year-over-year revenue change (16.1% vs 9.8%). LCI INDUSTRIES produced more free cash flow last quarter ($64.3M vs $60.0M). Over the past eight quarters, Bausch & Lomb Corp's revenue compounded faster (13.1% CAGR vs -1.8%).

Bausch & Lomb is an American-Canadian eye health products company based in Vaughan, Ontario, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York, in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch + Lomb was one of the oldest continually operating companies in the United States.

Lucky Core Industries Limited, formerly known as ICI Pakistan, is a Pakistani conglomerate company headquartered in Karachi. It manufactures polyester, pharmaceutical, agrochemical, soda ash, and veterinary medicine.

BLCO vs LCII — Head-to-Head

Bigger by revenue
BLCO
BLCO
1.5× larger
BLCO
$1.4B
$932.7M
LCII
Growing faster (revenue YoY)
LCII
LCII
+6.4% gap
LCII
16.1%
9.8%
BLCO
Higher net margin
LCII
LCII
6.1% more per $
LCII
2.0%
-4.1%
BLCO
More free cash flow
LCII
LCII
$4.3M more FCF
LCII
$64.3M
$60.0M
BLCO
Faster 2-yr revenue CAGR
BLCO
BLCO
Annualised
BLCO
13.1%
-1.8%
LCII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BLCO
BLCO
LCII
LCII
Revenue
$1.4B
$932.7M
Net Profit
$-58.0M
$18.7M
Gross Margin
22.1%
Operating Margin
8.0%
3.8%
Net Margin
-4.1%
2.0%
Revenue YoY
9.8%
16.1%
Net Profit YoY
-1833.3%
95.7%
EPS (diluted)
$-0.16
$0.79

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLCO
BLCO
LCII
LCII
Q4 25
$1.4B
$932.7M
Q3 25
$1.3B
$1.0B
Q2 25
$1.3B
$1.1B
Q1 25
$1.1B
$1.0B
Q4 24
$1.3B
$803.1M
Q3 24
$1.2B
$915.5M
Q2 24
$1.2B
$1.1B
Q1 24
$1.1B
$968.0M
Net Profit
BLCO
BLCO
LCII
LCII
Q4 25
$-58.0M
$18.7M
Q3 25
$-28.0M
$62.5M
Q2 25
$-62.0M
$57.6M
Q1 25
$-212.0M
$49.4M
Q4 24
$-3.0M
$9.5M
Q3 24
$4.0M
$35.6M
Q2 24
$-151.0M
$61.2M
Q1 24
$-167.0M
$36.5M
Gross Margin
BLCO
BLCO
LCII
LCII
Q4 25
22.1%
Q3 25
24.4%
Q2 25
24.4%
Q1 25
24.1%
Q4 24
21.1%
Q3 24
24.0%
Q2 24
25.3%
Q1 24
23.1%
Operating Margin
BLCO
BLCO
LCII
LCII
Q4 25
8.0%
3.8%
Q3 25
7.4%
7.3%
Q2 25
-0.9%
7.9%
Q1 25
-7.3%
7.8%
Q4 24
6.8%
2.0%
Q3 24
3.6%
5.9%
Q2 24
2.1%
8.6%
Q1 24
0.5%
6.0%
Net Margin
BLCO
BLCO
LCII
LCII
Q4 25
-4.1%
2.0%
Q3 25
-2.2%
6.0%
Q2 25
-4.9%
5.2%
Q1 25
-18.6%
4.7%
Q4 24
-0.2%
1.2%
Q3 24
0.3%
3.9%
Q2 24
-12.4%
5.8%
Q1 24
-15.2%
3.8%
EPS (diluted)
BLCO
BLCO
LCII
LCII
Q4 25
$-0.16
$0.79
Q3 25
$-0.08
$2.55
Q2 25
$-0.18
$2.29
Q1 25
$-0.60
$1.94
Q4 24
$-0.00
$0.37
Q3 24
$0.01
$1.39
Q2 24
$-0.43
$2.40
Q1 24
$-0.48
$1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLCO
BLCO
LCII
LCII
Cash + ST InvestmentsLiquidity on hand
$383.0M
$222.6M
Total DebtLower is stronger
$5.0B
$945.2M
Stockholders' EquityBook value
$6.4B
$1.4B
Total Assets
$14.0B
$3.2B
Debt / EquityLower = less leverage
0.78×
0.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLCO
BLCO
LCII
LCII
Q4 25
$383.0M
$222.6M
Q3 25
$310.0M
$199.7M
Q2 25
$266.0M
$191.9M
Q1 25
$202.0M
$231.2M
Q4 24
$305.0M
$165.8M
Q3 24
$329.0M
$161.2M
Q2 24
$285.0M
$130.4M
Q1 24
$315.0M
$22.6M
Total Debt
BLCO
BLCO
LCII
LCII
Q4 25
$5.0B
$945.2M
Q3 25
$5.0B
$947.8M
Q2 25
$5.0B
$948.0M
Q1 25
$4.8B
$938.3M
Q4 24
$4.8B
$757.3M
Q3 24
$4.6B
$822.5M
Q2 24
$4.6B
$829.7M
Q1 24
$4.6B
$855.3M
Stockholders' Equity
BLCO
BLCO
LCII
LCII
Q4 25
$6.4B
$1.4B
Q3 25
$6.4B
$1.4B
Q2 25
$6.4B
$1.4B
Q1 25
$6.4B
$1.4B
Q4 24
$6.5B
$1.4B
Q3 24
$6.6B
$1.4B
Q2 24
$6.5B
$1.4B
Q1 24
$6.7B
$1.4B
Total Assets
BLCO
BLCO
LCII
LCII
Q4 25
$14.0B
$3.2B
Q3 25
$13.8B
$3.2B
Q2 25
$13.8B
$3.2B
Q1 25
$13.4B
$3.1B
Q4 24
$13.5B
$2.9B
Q3 24
$13.5B
$3.0B
Q2 24
$13.3B
$3.0B
Q1 24
$13.3B
$3.0B
Debt / Equity
BLCO
BLCO
LCII
LCII
Q4 25
0.78×
0.69×
Q3 25
0.77×
0.70×
Q2 25
0.77×
0.68×
Q1 25
0.76×
0.69×
Q4 24
0.74×
0.55×
Q3 24
0.70×
0.58×
Q2 24
0.71×
0.60×
Q1 24
0.69×
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLCO
BLCO
LCII
LCII
Operating Cash FlowLast quarter
$136.0M
$78.9M
Free Cash FlowOCF − Capex
$60.0M
$64.3M
FCF MarginFCF / Revenue
4.3%
6.9%
Capex IntensityCapex / Revenue
5.4%
1.6%
Cash ConversionOCF / Net Profit
4.22×
TTM Free Cash FlowTrailing 4 quarters
$-66.0M
$278.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLCO
BLCO
LCII
LCII
Q4 25
$136.0M
$78.9M
Q3 25
$137.0M
$97.2M
Q2 25
$35.0M
$112.2M
Q1 25
$-25.0M
$42.7M
Q4 24
$22.0M
$106.6M
Q3 24
$154.0M
$78.4M
Q2 24
$15.0M
$192.9M
Q1 24
$41.0M
$-7.7M
Free Cash Flow
BLCO
BLCO
LCII
LCII
Q4 25
$60.0M
$64.3M
Q3 25
$63.0M
$80.9M
Q2 25
$-54.0M
$99.5M
Q1 25
$-135.0M
$33.7M
Q4 24
$-70.0M
$95.7M
Q3 24
$94.0M
$68.3M
Q2 24
$-57.0M
$180.2M
Q1 24
$-26.0M
$-16.3M
FCF Margin
BLCO
BLCO
LCII
LCII
Q4 25
4.3%
6.9%
Q3 25
4.9%
7.8%
Q2 25
-4.2%
9.0%
Q1 25
-11.9%
3.2%
Q4 24
-5.5%
11.9%
Q3 24
7.9%
7.5%
Q2 24
-4.7%
17.1%
Q1 24
-2.4%
-1.7%
Capex Intensity
BLCO
BLCO
LCII
LCII
Q4 25
5.4%
1.6%
Q3 25
5.8%
1.6%
Q2 25
7.0%
1.2%
Q1 25
9.7%
0.9%
Q4 24
7.2%
1.4%
Q3 24
5.0%
1.1%
Q2 24
5.9%
1.2%
Q1 24
6.1%
0.9%
Cash Conversion
BLCO
BLCO
LCII
LCII
Q4 25
4.22×
Q3 25
1.55×
Q2 25
1.95×
Q1 25
0.86×
Q4 24
11.17×
Q3 24
38.50×
2.20×
Q2 24
3.15×
Q1 24
-0.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLCO
BLCO

Overthe Counter Products$489.0M35%
Pharmaceuticals$378.0M27%
Other$263.0M19%
Surgical$249.0M18%
Brandedand Other Generic Products$14.0M1%
Other Revenues$3.0M0%
Pharmaceutical Products$2.0M0%

LCII
LCII

Travel Trailer And Fifth Wheels$378.4M41%
Chassis Chassis Partsand Slideout Mechanisms$206.1M22%
Furnitureand Mattresses$120.4M13%
Appliances$69.9M7%
Other Products$69.1M7%
Axlesand Suspension Solutions$62.3M7%
Motorhomes$34.2M4%

Related Comparisons